What Should Investors Know About Ventas (VTR) Stock?

By Blake Campbell • Monday, November 07 12:00 • Permanent Link

Shares of Healthcare Facilities Real Estate Investment Trust company Ventas jumped 3.3% today. With many investors piling into VTR without a second thought, it may be a good idea to take a closer look at the stock. Here are some quick facts to get you started:

Ventas has moved -24.8% over the last year, and the S&P 500 logged a change of -19.8%
VTR has an average analyst rating of buy and is -23.48% away from its mean target price of $53.33 per share
Its trailing earnings per share (Eps) is $0.05
Ventas has a trailing 12 month Price to Earnings (P/E) ratio of 816.2 while the S&P 500 average is 15.97
Its forward earnings per share (Eps) is $0.45 and its forward P/E ratio is 90.7
The company has a Price to Book (P/B) ratio of 1.6 in contrast to the S&P 500's average ratio of 2.95
Ventas is part of the Real Estate sector, which has an average P/E ratio of 27.16 and an average P/B of 2.39
VTR has reported YOY quarterly earnings growth of -98.0% and gross profit margins of 44.3%
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

At Market Interference, we believe in giving retail investors access to timely and accurate data to help inform their investment decisions. subscribe to our free newsletter today to keep track of each day's market movers!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.